USHR Urges Congressional Action In Response To FDA’S Misguided Promotion Of Incomplete CBD Safety Data
Cannabis Law Report
MAY 31, 2023
Food and Drug Administration (FDA) webinar for hemp industry stakeholders, “A New Way Forward for Cannabidiol and Other Hemp Products,” U.S. General Counsel Jonathan Miller Raises Concerns Regarding FDA’s Stance on CBD Regulation WASHINGTON D.C. — On the heels of last week’s U.S.
Let's personalize your content